These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 20950119)
1. 5-Fluorouracil/Leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma: a clinical experience. Podolsky L; Oh M; Subbarayan PR; Francheschi D; Livingstone A; Ardalan B Acta Oncol; 2011 May; 50(4):602-5. PubMed ID: 20950119 [No Abstract] [Full Text] [Related]
2. A phase I study of 5-fluorouracil/leucovorin and arsenic trioxide for patients with refractory/relapsed colorectal carcinoma. Ardalan B; Subbarayan PR; Ramos Y; Gonzalez M; Fernandez A; Mezentsev D; Reis I; Duncan R; Podolsky L; Lee K; Lima M; Ganjei-Azar P Clin Cancer Res; 2010 Jun; 16(11):3019-27. PubMed ID: 20501625 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide suppresses thymidylate synthase in 5-FU-resistant colorectal cancer cell line HT29 In Vitro re-sensitizing cells to 5-FU. Subbarayan PR; Lee K; Ardalan B Anticancer Res; 2010 Apr; 30(4):1157-62. PubMed ID: 20530422 [TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer. Chau I; Webb A; Cunningham D; Hill M; Waters JS; Norman A; Massey A Br J Cancer; 2001 Nov; 85(9):1258-64. PubMed ID: 11720458 [TBL] [Abstract][Full Text] [Related]
5. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin. Pronzato P; Vaira F; Vigani A; Losardo P; Bertelli G Anticancer Res; 1995; 15(6B):2679-82. PubMed ID: 8669846 [TBL] [Abstract][Full Text] [Related]
6. Mitomycin-C, 5-fluorouracil, and leucovorin as a salvage therapy in patients with metastatic colorectal adenocarcinoma. Kang EJ; Choi YJ; Kim JS; Kim ST; Park KH; Choi IK; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH Asia Pac J Clin Oncol; 2010 Dec; 6(4):286-91. PubMed ID: 21114778 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan. Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736 [TBL] [Abstract][Full Text] [Related]
10. [Clinical study of 5-Fluorouracil and l-Leucovorin therapy for 56 patients with advanced recurrent colorectal carcinoma]. Matsuda T; Ogino K; Hiroyoshi M; Fujita H; Itoh T; Toyama H; Kawai Y; Makita D; Tsunemi K; Moritomo H; Nakamura T Gan To Kagaku Ryoho; 2006 Jun; 33(6):783-7. PubMed ID: 16770097 [TBL] [Abstract][Full Text] [Related]
11. [Combination of 5-fluorouracil and high doses of folinic acid in the treatment of recurrent and persistent spinocellular carcinoma of the head and neck. A phase II study]. Bacigalupo A; Benasso M; Cavallari M; Merlano M; Sampietro M; Scasso F; Pallestrini E; Barbieri A; Cantoni E; Grimaldi A Acta Otorhinolaryngol Ital; 1988; 8(6):575-80. PubMed ID: 3266818 [No Abstract] [Full Text] [Related]
12. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601 [TBL] [Abstract][Full Text] [Related]
13. Biochemical modulation in the treatment of advanced cancer: a study of combined leucovorin, fluorouracil, and iododeoxyuridine. Marshall JL; Richmond E; DeLap RJ Clin Cancer Res; 1996 Sep; 2(9):1475-80. PubMed ID: 9816323 [TBL] [Abstract][Full Text] [Related]
14. [Combination therapy including mutamycin (mitomycin C) in the treatment of advanced colorectal and gastric cancer]. Manziuk LV; Artamonova EV; Sholokhov VN; Strygina EA Vopr Onkol; 2001; 47(6):736-9. PubMed ID: 11826500 [TBL] [Abstract][Full Text] [Related]
15. Another study of how to give fluorouracil? Saltz LB J Clin Oncol; 2003 Oct; 21(20):3711-2. PubMed ID: 12963699 [No Abstract] [Full Text] [Related]
16. [Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma]. Natali M; D'Aprile M; Tonini G; Leggio M; Vici P; Carpano S; Angelini F; Carassai A; Lopez M Clin Ter; 1990 Jul; 134(1):25-30. PubMed ID: 2147605 [TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. Alberts SR; Horvath WL; Sternfeld WC; Goldberg RM; Mahoney MR; Dakhil SR; Levitt R; Rowland K; Nair S; Sargent DJ; Donohue JH J Clin Oncol; 2005 Dec; 23(36):9243-9. PubMed ID: 16230673 [TBL] [Abstract][Full Text] [Related]
18. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery]. Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396 [No Abstract] [Full Text] [Related]
19. A Phase II trial of oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX4) as first-line chemotherapy in advanced colorectal cancer: a China single-center experience. Xu N; Fang WJ; Zhang XC; Yu LF; Bao HY; Shi GM; Huang S; Shen P Cancer Invest; 2007; 25(7):599-605. PubMed ID: 17882631 [TBL] [Abstract][Full Text] [Related]
20. Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer. Nobile MT; Barzacch MC; Sanguineti O; Chiara S; Gozza A; Vincenti M; Lavarello A; Cognein P; Lionetto R; Percivale PL; Bertoglio S; Murolo C; Esposito M; Vannozzi MO; Rosso R Anticancer Res; 1998; 18(1B):517-21. PubMed ID: 9568171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]